STOCK TITAN

[Form 4] Kewaunee Scientific Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Kewaunee Scientific (KEQU) filed a Form 4 showing that Chief Financial Officer Donald T. Gardner III received an equity award of 9,047 restricted stock units on 06/25/2025. The grant is evenly split: 50% service-based RSUs vest in three equal annual installments beginning 06/30/2026, while 50% are performance-based and vest only if three-year performance goals are achieved. Following the transaction, the CFO beneficially owns 9,047 derivative securities. No open-market buys or sells of common shares were reported, and the filing contains no other material events.

Kewaunee Scientific (KEQU) ha presentato un Modulo 4 che mostra come il Direttore Finanziario Donald T. Gardner III abbia ricevuto un premio azionario di 9.047 unità azionarie vincolate il 25/06/2025. Il premio è suddiviso equamente: il 50% delle RSU basate sul servizio maturano in tre rate annuali uguali a partire dal 30/06/2026, mentre il restante 50% è basato sulle performance e matura solo se vengono raggiunti gli obiettivi di performance triennali. Dopo questa operazione, il CFO detiene beneficiariamente 9.047 strumenti derivati. Non sono stati segnalati acquisti o vendite di azioni ordinarie sul mercato aperto e la comunicazione non riporta altri eventi rilevanti.

Kewaunee Scientific (KEQU) presentó un Formulario 4 que muestra que el Director Financiero Donald T. Gardner III recibió una concesión de acciones por 9,047 unidades restringidas el 25/06/2025. La concesión se divide equitativamente: el 50% de las RSU basadas en servicio se consolidan en tres cuotas anuales iguales a partir del 30/06/2026, mientras que el 50% restante es basado en rendimiento y solo se consolida si se alcanzan los objetivos de desempeño a tres años. Tras la transacción, el CFO posee beneficiosamente 9,047 valores derivados. No se reportaron compras o ventas en el mercado abierto de acciones comunes y la presentación no contiene otros eventos materiales.

Kewaunee Scientific (KEQU)는 최고재무책임자 도널드 T. 가드너 3세가 2025년 6월 25일에 9,047개의 제한 주식 단위를 받은 것을 보여주는 Form 4를 제출했습니다. 이 보상은 균등하게 나뉘며, 50%는 서비스 기반 RSU로 2026년 6월 30일부터 3년에 걸쳐 동일한 연간 할부로 베스팅되고, 나머지 50%는 성과 기반으로 3년간 성과 목표 달성 시에만 베스팅됩니다. 거래 후 CFO는 9,047개의 파생 증권을 실질적으로 보유하게 됩니다. 보통주에 대한 공개 시장 매수나 매도는 보고되지 않았으며, 제출서에는 다른 중요한 사건도 포함되어 있지 않습니다.

Kewaunee Scientific (KEQU) a déposé un formulaire 4 indiquant que le directeur financier Donald T. Gardner III a reçu une attribution d'actions de 9 047 unités d'actions restreintes le 25/06/2025. Cette attribution est répartie équitablement : 50 % des RSU basées sur le service sont acquises en trois versements annuels égaux à partir du 30/06/2026, tandis que les 50 % restants sont basés sur la performance et ne sont acquis que si les objectifs de performance sur trois ans sont atteints. Suite à cette opération, le directeur financier détient de manière bénéficiaire 9 047 titres dérivés. Aucun achat ou vente d'actions ordinaires sur le marché ouvert n'a été signalé, et le dépôt ne contient aucun autre événement important.

Kewaunee Scientific (KEQU) hat ein Formular 4 eingereicht, das zeigt, dass Finanzvorstand Donald T. Gardner III am 25.06.2025 eine Aktienzuteilung von 9.047 Restricted Stock Units erhalten hat. Die Zuteilung ist gleichmäßig aufgeteilt: 50 % der auf Dienstzeit basierenden RSUs werden in drei gleichen jährlichen Raten ab dem 30.06.2026 fällig, während die anderen 50 % leistungsbasiert sind und nur bei Erreichen der dreijährigen Leistungsziele vesten. Nach der Transaktion besitzt der CFO wirtschaftlich 9.047 derivative Wertpapiere. Keine Käufe oder Verkäufe von Stammaktien im offenen Markt wurden gemeldet, und die Meldung enthält keine weiteren wesentlichen Ereignisse.

Positive
  • None.
Negative
  • None.

Kewaunee Scientific (KEQU) ha presentato un Modulo 4 che mostra come il Direttore Finanziario Donald T. Gardner III abbia ricevuto un premio azionario di 9.047 unità azionarie vincolate il 25/06/2025. Il premio è suddiviso equamente: il 50% delle RSU basate sul servizio maturano in tre rate annuali uguali a partire dal 30/06/2026, mentre il restante 50% è basato sulle performance e matura solo se vengono raggiunti gli obiettivi di performance triennali. Dopo questa operazione, il CFO detiene beneficiariamente 9.047 strumenti derivati. Non sono stati segnalati acquisti o vendite di azioni ordinarie sul mercato aperto e la comunicazione non riporta altri eventi rilevanti.

Kewaunee Scientific (KEQU) presentó un Formulario 4 que muestra que el Director Financiero Donald T. Gardner III recibió una concesión de acciones por 9,047 unidades restringidas el 25/06/2025. La concesión se divide equitativamente: el 50% de las RSU basadas en servicio se consolidan en tres cuotas anuales iguales a partir del 30/06/2026, mientras que el 50% restante es basado en rendimiento y solo se consolida si se alcanzan los objetivos de desempeño a tres años. Tras la transacción, el CFO posee beneficiosamente 9,047 valores derivados. No se reportaron compras o ventas en el mercado abierto de acciones comunes y la presentación no contiene otros eventos materiales.

Kewaunee Scientific (KEQU)는 최고재무책임자 도널드 T. 가드너 3세가 2025년 6월 25일에 9,047개의 제한 주식 단위를 받은 것을 보여주는 Form 4를 제출했습니다. 이 보상은 균등하게 나뉘며, 50%는 서비스 기반 RSU로 2026년 6월 30일부터 3년에 걸쳐 동일한 연간 할부로 베스팅되고, 나머지 50%는 성과 기반으로 3년간 성과 목표 달성 시에만 베스팅됩니다. 거래 후 CFO는 9,047개의 파생 증권을 실질적으로 보유하게 됩니다. 보통주에 대한 공개 시장 매수나 매도는 보고되지 않았으며, 제출서에는 다른 중요한 사건도 포함되어 있지 않습니다.

Kewaunee Scientific (KEQU) a déposé un formulaire 4 indiquant que le directeur financier Donald T. Gardner III a reçu une attribution d'actions de 9 047 unités d'actions restreintes le 25/06/2025. Cette attribution est répartie équitablement : 50 % des RSU basées sur le service sont acquises en trois versements annuels égaux à partir du 30/06/2026, tandis que les 50 % restants sont basés sur la performance et ne sont acquis que si les objectifs de performance sur trois ans sont atteints. Suite à cette opération, le directeur financier détient de manière bénéficiaire 9 047 titres dérivés. Aucun achat ou vente d'actions ordinaires sur le marché ouvert n'a été signalé, et le dépôt ne contient aucun autre événement important.

Kewaunee Scientific (KEQU) hat ein Formular 4 eingereicht, das zeigt, dass Finanzvorstand Donald T. Gardner III am 25.06.2025 eine Aktienzuteilung von 9.047 Restricted Stock Units erhalten hat. Die Zuteilung ist gleichmäßig aufgeteilt: 50 % der auf Dienstzeit basierenden RSUs werden in drei gleichen jährlichen Raten ab dem 30.06.2026 fällig, während die anderen 50 % leistungsbasiert sind und nur bei Erreichen der dreijährigen Leistungsziele vesten. Nach der Transaktion besitzt der CFO wirtschaftlich 9.047 derivative Wertpapiere. Keine Käufe oder Verkäufe von Stammaktien im offenen Markt wurden gemeldet, und die Meldung enthält keine weiteren wesentlichen Ereignisse.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gardner Donald T. III

(Last) (First) (Middle)
2700 WEST FRONT STREET

(Street)
STATESVILLE NC 28677

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units FY26 (1) 06/25/2025 A 9,047 (2) (2) Common Stock 9,047 $0 9,047 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
2. The award of restricted stock units shall vest as follows: (a) 50% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning June 30, 2026, subject to the reporting person's continued employment with the Company; and (b) 50% of the number of restricted stock units subject to the award consist of performance-based restricted stock units that will vest only if performance goals are achieved over a three-year period. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the three-year performance period.
Remarks:
/s/ Donald T. Gardner III 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did KEQU's CFO receive in the latest Form 4 filing?

The filing reports an award of 9,047 restricted stock units to CFO Donald T. Gardner III.

Did the KEQU insider buy or sell any common stock on the open market?

No. The Form 4 shows only an RSU grant; there were no open-market purchases or sales of KEQU common shares.
Kewaunee Scienti

NASDAQ:KEQU

KEQU Rankings

KEQU Latest News

KEQU Latest SEC Filings

KEQU Stock Data

105.36M
2.13M
24.44%
44.44%
1.62%
Furnishings, Fixtures & Appliances
Laboratory Apparatus & Furniture
Link
United States
STATESVILLE